| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8830663 | The American Journal of Surgery | 2018 | 4 Pages |
Abstract
- Response to neoadjuvant chemotherapy for breast cancer varies by tumor subtype.
- Tumor subtype and surgical treatment plan should drive decision making.
- Sentinel lymph node biopsy after neoadjuvant chemotherapy can reduce morbidity.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Kristen MD, FACS,